Topics

Suicidal Behavior in Psoriasis: The Case of Brodalumab

08:00 EDT 13 Sep 2019 | Medscape

Suicidal ideation has been reported in psoriasis patients treated with brodalumab, which led to a black box warning. Is there enough evidence to establish causality, or are other factors involved?
Skin Therapy Letter

Original Article: Suicidal Behavior in Psoriasis: The Case of Brodalumab

NEXT ARTICLE

More From BioPortfolio on "Suicidal Behavior in Psoriasis: The Case of Brodalumab"

Quick Search

Relevant Topics

Alzumab (Itolizumab)
Biocon Launches ALZUMAb™ - a ‘First in Class’ Novel Biologic Treatment for Psoriasis Patients in India • ALZUMAb™-World's first novel anti-CD6 antibody developed by Biocon to address a large unmet need for th...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...